The company said clearing and transaction fee revenue for Q1 2024 included $69.1 million in transaction fees from its cash markets business, compared with $75.0 million for Q1 2023.

1. 01

   The company said clearing and transaction fee revenue for Q1 2024 included $69.1 million in transaction fees from its cash markets business, compared with $75.0 million for Q1 2023.

2. 02

   CME Group said operating expenses rose by $0.4 million in Q1 2024 compared with Q1 2023. The company cited higher technology support services, license fees and stock-based compensation as factors behind the increase.

3. 03

   CME Group said earnings from reinvesting cash performance bond and guaranty fund contributions fell to $1,036.7 million in Q1 2024, compared with $1,256.3 million in Q1 2023. Expenses related to the distribution of interest earned on collateral reinvestments to clearing firms declined to $967.4 million from $1,163.5 million.

4. 04

   The company said it had no borrowings outstanding under its $2.3 billion senior revolving credit facility as of March 31, 2024, and had approximately $2.3 billion of excess borrowing capacity. It said cash and cash equivalents were $1.4 billion, down from $2.9 billion as of December 31, 2023.

Key figures

Quarter ended March 31, 2024

Revenue

$1.5B

Operating income

$960M

Net income

$855M

EPS

$2.35

Operating cash flow

$893M

Analysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.